Study Clears Gene Therapy in Death of Arthritis Patient, University of Chicago Researchers Say

MedPage Today -- PRINCETON, N.J., July 8 -- The death of a young patient participating in a gene-therapy trial for a rheumatoid arthritis drug was most likely the result of another arthritis drug, adalimumab (Humira), and not the novel gene therapy agent, a new study found.